about
Glycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune RecognitionIncreasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognitionPericellular proteolysis in cancerGenetics, genomics, and evolutionary biology of NKG2D ligands.Expression and prognostic significance of unique ULBPs in pancreatic cancerGeneration of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.NKG2D signaling in cancer immunosurveillance.MICA SNPs and the NKG2D system in virus-induced HCC.Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretionAlternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.The crude extract of Corni Fructus inhibits the migration and invasion of U-2 OS human osteosarcoma cells through the inhibition of matrix metalloproteinase-2/-9 by MAPK signaling.Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer - significance and development.Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention.A novel recombinant Salmonella vaccine enhances the innate immunity of NK cells against acute myeloid leukaemia cells Kasumi-1 in vitro.Natural killer cells and tumor metastasis.Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma.
P2860
Q28076151-740BCD02-6260-4CBA-B38B-72E7D6401CEFQ33761979-A6D78178-C025-412C-8CCE-429DC3E2E1FAQ34430691-9B42267A-BB80-4497-98A2-90ADE2A3A100Q34489980-5F2B5D57-81C6-4E37-BA99-840865FC126FQ37229770-700511F1-8888-4333-836D-70D92A636DBBQ38107250-790FD9D1-6916-448F-B592-4B6721029949Q38194944-32E1AA2A-F805-4810-AC6A-610752F71AB3Q38255751-60E49B38-B075-4242-86A5-A3B575683F39Q38706890-D64771F6-8F83-46FE-B8CB-8C8AB9EA06C8Q38762336-C399423F-322B-4C6E-93AA-88FFBC5F1F99Q38940720-14D2D383-1625-4C98-94AF-07991A759895Q39108567-57D234C5-40A3-440C-B934-106D60111210Q39164701-5ECDFC43-CD5D-421B-A4FA-82FB8756C20AQ39176227-CDFC63C6-FD2F-44BE-BECE-9002AF7EEF42Q42688261-3D7BDEE9-3F73-4C36-B15F-7292680B1483Q42702237-0C73640E-CBB7-4434-A9C6-9DD82AE2BE16Q45281138-2434A6BE-A552-4948-90BE-C5EBCC7231B3Q48130583-5D4F9D16-5F46-46CC-B8D2-6684B7790BBAQ53140686-39B828A1-678B-4C2F-A570-A760CA761ED7Q53446053-B130EF0B-9A1D-4C57-BCE3-AE35EB642955
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MMP9 mediates MICA shedding in human osteosarcomas.
@en
MMP9 mediates MICA shedding in human osteosarcomas.
@nl
type
label
MMP9 mediates MICA shedding in human osteosarcomas.
@en
MMP9 mediates MICA shedding in human osteosarcomas.
@nl
prefLabel
MMP9 mediates MICA shedding in human osteosarcomas.
@en
MMP9 mediates MICA shedding in human osteosarcomas.
@nl
P2093
P2860
P356
P1476
MMP9 mediates MICA shedding in human osteosarcomas.
@en
P2093
P2860
P304
P356
10.1042/CBI20100431
P577
2011-06-01T00:00:00Z